Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study of Eszopiclone Co-administered With Venlafaxine in Subjects With Major Depressive Disorder and Insomnia
This study has been completed.
Study NCT00435279 Information provided by Sepracor, Inc.
First Received: February 12, 2007 Last Updated: October 9, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Major Depressive Disorder
Insomnia
Additional conditions recognized in this trial
Depression
Depressive Disorder
Depressive Disorder, Major
Disease
Sleep Initiation and Maintenance Disorders
More general conditions related to this trial
Behavioral Symptoms
Dyssomnias
Mental Disorders
Mood Disorders
Nervous System Diseases
Pathologic Processes
Sleep Disorders
Sleep Disorders, Intrinsic
Interventions listed in this trial
Eszopiclone
Placebo
Venlafaxine
More general drug interventions related to this trial
Antidepressive Agents
Antidepressive Agents, Second-Generation
Central Nervous System Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Uptake Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Sepracor, Inc.
Back to top of Main Content
